Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study

Zhou, Q; Zhang, HL; Jiang, LY; Shi, YK; Chen, Y; Yu, JM; Zhou, CC; He, Y; Hu, YP; Liang, ZA; Pan, YY; Zhuo, WL; Song, Y; Wu, G; Chen, GY; Lu, Y; Zhang, CY; Zhang, YP; Cheng, Y; Lu, S; Wang, CL; Zhou, JY; Liu, YP; He, JX; Wang, J; Wu, YL

Wu, YL (通讯作者)，Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (12): 10771

Abstract

PurposeASTRIS study aimed the largest to evaluate the effectiveness and safety of second- or higher-line osimertinib in patients with advanced/metasta......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索